Medicare Enrolled

Dr. Anna Tseng, MD

Neurology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
8390 LYNDON B JOHNSON FWY STE 400, Dallas, TX 75243
2147509977
In practice since 2006 (19 years)
NPI: 1053417964 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tseng from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tseng? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tseng

Dr. Anna Tseng is a neurology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Tseng performed 4,430 Medicare services across 117 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tseng received a total of $7,702 from 74 pharmaceutical and/or device companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tseng is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 13% volume in TX$ $7,702 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,430
Medicare services
Top 13% in TX for neurology
117
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~233 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit4,264$5$7
Office visit, established patient (30-39 min)120$90$215
Office visit, established patient (20-29 min)35$61$175
Mri scan of brain before and after contrast11$159$1,696
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,702
Total received (2018-2024)
Avg $1,100/year across 7 years
Top 32% in TX for neurology
74
Companies
411
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,612 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,719
2023
$1,231
2022
$1,281
2021
$496
2020
$662
2019
$1,050
2018
$1,262

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$737
UCB, Inc.
$502
AbbVie Inc.
$459
Biogen, Inc.
$440
Novartis Pharmaceuticals Corporation
$430
PFIZER INC.
$376
Genentech USA, Inc.
$372
Eisai Inc.
$292
Lilly USA, LLC
$226
Alexion Pharmaceuticals, Inc.
$226
Abbott Laboratories
$203
AbbVie, Inc.
$197
Merz Pharmaceuticals, LLC
$162
TG THERAPEUTICS, INC.
$127
Lundbeck LLC
$125
ACADIA Pharmaceuticals Inc
$122
Amgen Inc.
$122
ARGENX US, INC.
$119
Biohaven Pharmaceutical Holding Company Ltd.
$117
Adamas Pharmaceuticals, Inc.
$116
Teva Pharmaceuticals USA, Inc.
$107
EMD Serono, Inc.
$106
Neurocrine Biosciences, Inc.
$105
Avanir Pharmaceuticals, Inc.
$98
GENZYME CORPORATION
$96
Acorda Therapeutics, Inc
$90
CSL Behring
$89
Allergan Inc.
$87
Merz North America, Inc.
$84
SK Life Science, Inc.
$80
Grifols USA, LLC
$80
Amneal Pharmaceuticals LLC
$68
Bayer HealthCare Pharmaceuticals Inc.
$65
Allergan, Inc.
$65
Kedrion Biopharma, Inc.
$65
Akcea Therapeutics, Inc.
$51
HOSPIRA, INC.
$48
Ipsen Biopharmaceuticals, Inc
$47
GE HEALTHCARE
$41
Kyowa Kirin, Inc.
$40
Horizon Therapeutics plc
$40
Upsher-Smith Laboratories LLC
$39
Neurelis, Inc.
$38
ASSERTIO THERAPEUTICS, Inc.
$34
IMPEL PHARMACEUTICALS INC.
$34
AQUESTIVE THERAPEUTICS, INC.
$31
MERZ NORTH AMERICA, INC.
$28
Celgene Corporation
$28
Avion Pharmaceuticals
$27
Biohaven Pharmaceuticals, Inc.
$25
Averitas Pharma Inc.
$25
REVANCE THERAPEUTICS, INC.
$24
TG Therapeutics, Inc.
$23
Life Molecular Imaging Ltd
$20
Impax Laboratories, Inc.
$18
UPSHER-SMITH LABORATORIES LLC
$18
LivaNova USA, Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
Vertical Pharmaceuticals, LLC
$16
ANI Pharmaceuticals, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$16
Otsuka America Pharmaceutical, Inc.
$16
Janssen Pharmaceuticals, Inc
$15
EISAI INC.
$15
Currax Pharmaceuticals LLC
$15
GE Healthcare
$15
Mallinckrodt Enterprises LLC
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
US WorldMeds, LLC
$13
Assertio Therapeutics, Inc.
$13
Greenwich Biosciences, Inc.
$12
E.R. Squibb & Sons, L.L.C.
$12
Xeris Pharmaceuticals, Inc.
$12
Top 3 companies account for 22.0% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · CONFIRM RX · COPAXONE · Cambia · DAXXIFY · DAYBUE · DUOPA · DYSPORT · Deep Brain Stimulation · Dhivy · Duopa · Dysport · EMGALITY · Enspryng · Epidiolex · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · LYRICA · Leqembi · MAYZENT · MYOBLOC · Mavenclad · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SYMPAZAN · TECFIDERA · TEGSEDI · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · XEOMIN · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $174 per 100 Medicare services performed
Looking for a neurology in Dallas?
Compare neurologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
237
Per 100K population
9.1
County median income
$74,149
Nearest hospital
NEXUS CHILDRENS HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Tseng is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Tseng experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Tseng performed 4,264 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tseng receive payments from pharmaceutical companies?
Yes. Dr. Tseng received a total of $7,702 from 74 companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tseng's costs compare to other neurologys in Dallas?
Dr. Tseng's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tseng) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →